Candel Therapeutics Inc. (NASDAQ: CADL)
$8.7400
-0.0100 ( +1.42% ) 6.6K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$8.7400
Previous close
$8.7500
Volume
6.6K
Market cap
$389.16M
Day range
$8.5350 - $9.1590
52 week range
$1.1000 - $14.6000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Apr 04, 2024 |
| 8-k | 8K-related | 15 | Mar 28, 2024 |
| 10-k | Annual reports | 90 | Mar 28, 2024 |
| 8-k | 8K-related | 14 | Mar 06, 2024 |
| 8-k | 8K-related | 14 | Feb 13, 2024 |
| 3 | Insider transactions | 2 | Jan 19, 2024 |
| 8-k | 8K-related | 10 | Jan 12, 2024 |
| 8-k | 8K-related | 12 | Jan 03, 2024 |
| 8-k | 8K-related | 12 | Dec 15, 2023 |
| 8-k | 8K-related | 14 | Dec 12, 2023 |